65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03366142 (ClinicalTrials.gov)	July 2, 2018	7/12/2017	Ustekinumab(Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Typ ...	Use of Ustekinumab(Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficie ...	LAD1	Drug: Ustekinumab	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Recruiting	12 Years	65 Years	All	20	Phase 1/Phase 2	United States
2	NCT02199496 (ClinicalTrials.gov)	October 19, 2015	23/7/2014	Study of Safety, Tolerability, and Efficacy of Ustekinumabfor Symptomatic Gastrointestinal Inflammat ...	An Open-Label Phase I/II Pilot Study to Assess the Safety/Tolerability and Efficacy of Ustekinumabfo ...	Gastrointestinal Inflammation Associated With CVID;CVID Enteropathy	Biological: Stelara (ustekinumab)	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	75 Years	All	5	Phase 1/Phase 2	United States

First Previous1Next Last